Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.4K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.4K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

950
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
950
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

924
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
924
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

517
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
517
Bile01:19

Bile

6.2K
Bile is a crucial bodily fluid, characterized by its yellow-green color and alkaline nature. Produced in the liver, it is transported through the common hepatic duct into either the cystic duct, leading to the gallbladder, or directly into the common bile duct. The flow of bile is regulated by the sphincter of Oddi located at the entrance of the duodenum. When this sphincter is closed, bile is redirected to the gallbladder for storage and concentration.
Bile is released when dietary fats enter...
6.2K
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

6.3K
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gallbladder neoplasia is associated with a higher incidence of cholangiocarcinoma in patients with primary sclerosing cholangitis.

Canadian liver journal·2026
Same author

Association of a Polygenic Risk Score with Diagnosis and Outcomes in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026
Same author

Patient Perspectives and Demographic Factors Influencing Non-Participation in a Large Genomics Study.

Mayo Clinic proceedings. Innovations, quality & outcomes·2026
Same author

Oral Vancomycin Is an Effective Therapy in Adult Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.

Gastro hep advances·2026
Same author

Vitamin B6 predicts poor outcomes in geographically distinct populations with primary sclerosing cholangitis.

Journal of hepatology·2026
Same author

Lipidomic characterization of bile and serum reveals an altered lipid landscape in end-stage primary sclerosing cholangitis.

Scientific reports·2026

Related Experiment Video

Updated: Apr 12, 2026

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
04:14

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Published on: February 28, 2025

1.1K

The Cholangiopathies.

Konstantinos N Lazaridis1, Nicholas F LaRusso1

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN.

Mayo Clinic Proceedings
|May 11, 2015
PubMed
Summary
This summary is machine-generated.

Cholangiopathies are progressive liver diseases targeting bile duct cells (cholangiocytes). Understanding their biology and pathogenesis is crucial for developing effective therapies for conditions like primary biliary cirrhosis and cholangiocarcinoma.

Related Experiment Videos

Last Updated: Apr 12, 2026

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
04:14

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Published on: February 28, 2025

1.1K

Area of Science:

  • Hepatology and Gastroenterology
  • Cell Biology
  • Pathology

Background:

  • Cholangiocytes, the epithelial cells lining bile ducts, play vital roles in bile modification, response to stimuli, and liver repair.
  • Cholangiopathies, diseases targeting cholangiocytes, cause significant morbidity and mortality due to their progressive nature and limited treatment options.
  • These conditions often lead to end-stage liver disease, necessitating liver transplantation and imposing a considerable economic burden.

Purpose of the Study:

  • To provide a concise summary of cholangiocyte biology.
  • To present a conceptual framework for cholangiopathy development.
  • To review recent advancements in understanding cholangiopathy pathogenesis and therapeutic strategies.

Main Methods:

  • Literature search of PubMed using keywords: cholangiocytes, biliary epithelia, cholestasis, cholangiopathy, biliary disease.
  • Inclusion of studies published within the past five years (June 1, 2009 - May 31, 2014).
  • Exclusion of non-English studies.

Main Results:

  • The review synthesizes current knowledge on cholangiocyte biology and disease development.
  • Recent progress in understanding the pathogenesis of six common cholangiopathies is discussed.
  • The impact of new scientific insights on therapeutic approaches for these conditions is highlighted.

Conclusions:

  • Cholangiopathies represent a significant challenge in liver disease management.
  • Advances in understanding cholangiocyte biology and disease mechanisms are paving the way for novel therapies.
  • Further research into cholangiopathies is essential for improving patient outcomes and reducing healthcare costs.